Mitsui Chemicals (4183) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
1 Nov, 2026Executive summary
FY2023 sales revenue fell 7% YoY to ¥1,749.7bn; operating income before special items declined 16% to ¥96.2bn, and net income attributable to owners fell 40% to ¥50.0bn.
FY2024 outlook targets revenue of ¥1,850.0bn, operating income before special items of ¥125.0bn, and net income attributable to owners of ¥73.0bn.
Financial highlights
FY2023 operating income was ¥74.1bn, down 43% YoY; income before taxes was ¥73.3bn, down 38%.
Sales revenue decreased ¥129.8bn YoY, with Basic & Green Materials accounting for a ¥167.2bn decline; Growth Domains revenue rose ¥37.7bn to ¥1,053.2bn.
FY2024 outlook: sales revenue +6% to ¥1,850.0bn; operating income before special items +30% to ¥125.0bn; operating income +52% to ¥113.0bn.
FY2024 outlook puts income before taxes at ¥107.0bn, up 46%, and net income attributable to owners at ¥73.0bn, up 46%.
Outlook and guidance
FY2024 operating income before special items is forecast to improve by ¥28.8bn, driven by a ¥41.5bn volume benefit and ¥9.0bn improvement in terms of trade, partly offset by ¥21.7bn higher costs.
FY2024 operating income before special items is projected at ¥52.0bn in H1 and ¥73.0bn in H2; the H2 increase reflects volume gains in agrochemicals, elastomers, solutions and semiconductor applications, plus Basic & Green Materials pricing.
FY2024 assumptions include a ¥145/$ exchange rate and domestic naphtha at ¥75,000/KL, versus ¥145/$ and ¥69,100/KL in FY2023.
Latest events from Mitsui Chemicals
- JSR deal aims to make ICT the lead profit engine, targeting ¥300bn+ FY30 core profit.4183
Corporate presentation - H1 earnings surged, guidance rose, and the ¥1.84tn JSR deal reset growth and funding plans.4183
Q2 2027 - Ambitious 2030 targets leverage ESG, DX, and AI for sustainable growth and operational excellence.4183
ESG presentation - Operating income before special items jumped 88% YoY in 1Q FY2026, led by specialty chemicals and restructuring.4183
Q1 2027 - Specialty chemicals lead profit growth as global expansion and sustainability accelerate.4183
Investor presentation - FY 2026 profit is set to rise on specialty chemicals growth and restructuring, despite external risks.4183
Q4 2026 - Profits fell on Basic & Green Materials weakness, but ICT Solutions and capital returns remain strong.4183
Q3 2026 - Strong YoY growth with positive outlook, but Osaka plant outage adds uncertainty.4183
Q1 2025 - FY2025 profit rebound is forecast despite net income drop and trade policy risks.4183
Q4 2025